MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-27-2026
Inogen Operating Expenses 2011-2026 | INGN
Annual Operating Expenses Inogen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 184 M | 197 M | 236 M | 239 M | 167 M | 150 M | 152 M | 141 M | 93.6 M | 74.4 M | 61.2 M | 45 M | 34.5 M | 23.1 M | 16.4 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 239 M | 16.4 M | 121 M |
Quarterly Operating Expenses Inogen
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 48.4 M | 47.5 M | 44 M | - | 49.1 M | 49.8 M | 50.6 M | - | 80.5 M | 45.8 M | 52.6 M | - | 53.1 M | 49.1 M | 48.6 M | - | 41.3 M | 38.7 M | 42 M | - | 35 M | 35.1 M | 40.5 M | - | 35.2 M | 38.1 M | 39.6 M | - | 38.4 M | 34.4 M | 29 M | - | 24.8 M | 23.1 M | 20.2 M | - | 19.7 M | 18.2 M | 18 M | - | 15.7 M | 15.5 M | 13.5 M | - | 11.1 M | 11.2 M | 10.4 M | - | 8.76 M | 8.66 M | 7.48 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 80.5 M | 7.48 M | 33.1 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
EDAP TMS S.A.
EDAP
|
47.1 M | $ 4.13 | -0.72 % | $ 155 M |  France |
 |
Apyx Medical Corporation
APYX
|
39.5 M | $ 3.67 | 3.09 % | $ 151 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | USA |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
614 M | $ 7.52 | -2.97 % | $ 1.13 B | USA |
 |
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | USA |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | USA |
 |
Helius Medical Technologies
HSDT
|
12.5 M | $ 2.22 | 3.26 % | $ 1.35 M | USA |
 |
BioSig Technologies
BSGM
|
71.1 M | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | USA |
 |
OrthoPediatrics Corp.
KIDS
|
212 M | $ 17.81 | 1.37 % | $ 418 M | USA |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
LENSAR
LNSR
|
32.6 M | $ 5.64 | 7.84 % | $ 67.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
15.3 M | $ 12.82 | 9.76 % | $ 363 M | USA |
 |
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | USA |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
Cytosorbents Corporation
CTSO
|
41.2 M | $ 0.61 | -0.08 % | $ 38 M | USA |
 |
LivaNova PLC
LIVN
|
697 M | $ 71.86 | 1.32 % | $ 3.92 B |  Britain |
 |
Delcath Systems
DCTH
|
72.8 M | $ 11.48 | 2.14 % | $ 411 M | USA |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Orthofix Medical
OFIX
|
344 M | $ 11.65 | -3.48 % | $ 461 M |  Curacao |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M |  Canada |
 |
IRIDEX Corporation
IRIX
|
21.8 M | $ 1.03 | - | $ 17.4 M | USA |
 |
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
126 M | - | - | $ 10.2 M | USA |
 |
Myomo
MYO
|
41.3 M | $ 0.83 | -5.05 % | $ 34.7 M | USA |
 |
Electromed
ELMD
|
40.3 M | $ 26.93 | 0.26 % | $ 228 M | USA |
 |
Butterfly Network
BFLY
|
123 M | $ 4.16 | -2.0 % | $ 881 M | USA |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
27.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Profound Medical Corp.
PROF
|
52.6 M | $ 6.85 | -4.33 % | $ 207 M | Canada |
 |
Insulet Corporation
PODD
|
531 M | $ 154.16 | -3.89 % | $ 10.8 B | USA |
 |
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | USA |
 |
Sintx Technologies
SINT
|
11.2 M | $ 2.35 | -2.08 % | $ 6.52 M | USA |
 |
Globus Medical
GMED
|
887 M | $ 77.95 | -8.37 % | $ 10.5 B | USA |
 |
CONMED Corporation
CNMD
|
648 M | $ 36.76 | -3.52 % | $ 1.14 B | USA |
 |
Stryker Corporation
SYK
|
11.2 B | $ 285.47 | -2.98 % | $ 109 B | USA |
 |
Inspire Medical Systems
INSP
|
240 M | $ 44.26 | -2.87 % | $ 1.3 B | USA |
 |
Integer Holdings Corporation
ITGR
|
279 M | $ 88.12 | 0.23 % | $ 3.06 B | USA |
 |
Invacare Corporation
IVC
|
260 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.99 B | $ 79.96 | -3.44 % | $ 46.8 B | USA |
 |
Tandem Diabetes Care
TNDM
|
159 M | $ 15.48 | -16.19 % | $ 1.05 B | USA |